MAP4K4 and hepatocellular carcinoma: To further confirm that MAP4K4 inhibition abrogated PEPT1‐mediated HCC metastasis, we treated Huh7 and PLC/PRF/5 cells with a specific MAP4K4 inhibitor, GNE‐495.